Vaginal candidosis: the place of butоconazol in pharmacotherapy
Vaginal candidosis is very common disease. To assess butоconazol therapeutical efficacy in treatment of chronic vaginal candidosis 58 patients in age of 22–48 years were examined. Inclusion criteria were: presence of history of 4 or more episodes of vaginal candidosis in an year, absence of sexually...
Main Authors: | G S Bogdanova, Z S Zaidieva, V A Zayakin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Berlin A.V.
2013-02-01
|
Series: | Гинекология |
Subjects: | |
Online Access: | https://gynecology.orscience.ru/2079-5831/article/view/28175 |
Similar Items
-
VAGINAL CANDIDOSIS. ALTERNATIVES OF PHARMACOTHERAPY
by: L. O. Makarov, et al.
Published: (2016-09-01) -
The role of metronidazole on the establishment and persistence of oral candidosis
by: Veronica Quispe Yujra, et al.
Published: (2015-11-01) -
Candida Albicans and Non-Albicans Species as Etiological Agent of Vaginitis in Pregnant and Non-Pregnant Women
by: Mirela Babić, et al.
Published: (2010-02-01) -
Pathogenesis and treatment of oral candidosis
by: David Williams, et al.
Published: (2011-01-01) -
Vulvovaginal Candidosis: Current Concepts, Challenges and Perspectives
by: Valentina Sustr, et al.
Published: (2020-11-01)